Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 10
Original Research
Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 18,080 | Dovepress* | 8,790+ | 1,315 | 10,105 | |
| PubMed Central* | 9,290 | 677 | 9,967 | ||
| Totals | 18,080 | 1,992 | 20,072 | ||
| *Since 4 May 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar